Bulletin from Moberg Pharma’s Extraordinary General Meeting on April 28[th], 2020
STOCKHOLM, April 28[th], 2020. Moberg Pharma AB (publ)’s (“Moberg Pharma” or the “Company”) Extraordinary General Meeting took place today in the Company’s premises in Bromma. The Extraordinary General Meeting resolved as set out below.Amendments to the articles of associationThe Extraordinary General Meeting resolved in accordance with the Board of Directors’ proposal to amend the Company’s articles of association regarding, inter alia, the limits for the Company’s share capital and number of shares, day for notice of attendance to a General Meeting, removal of certain provisions that